Strong activity in the pharmaceutical sector managed to keep the FTSE 100 up today after GlaxoSmithK...
Strong activity in the pharmaceutical sector managed to keep the FTSE 100 up today after GlaxoSmithKline suggested one of its new drugs will improve profits margins. Abbey National, however, prevented the index from improving on last week's losses and kept gains hovering just above its starting point. The FTSE 100 gained 7.8 points to 4928.2, led by advances from Glaxo and AstraZeneca which rose 3.8 and 4.1% respectively, but they were offset by declines in Abbey National, HBOS and Royal Bank of Scotland Group, after Abbey warned of ``substantially lower'' 2002 pretax profit. C...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes